Reciprocal expression of CD38 and CD34 by adult murine hematopoietic stem cells.

The effects of activation of adult murine stem cells on their expression of CD38 were studied using a murine transplantation model. First, the published finding that the majority of long-term engrafting cells from normal adult steady-state marrow are CD38(+) was confirmed. Next, it was determined that the majority of stem cells activated in vivo by injection of 5-fluorouracil (5-FU) or mobilized by granulocyte colony-stimulating factor are CD38(-). Stem cells that were activated in culture with interleukin-11 and steel factor were also CD38(-). Previous studies have shown that expression of CD34 by adult stem cells is also modulated by in vivo or in vitro activation. To determine whether there is reciprocal expression of CD38 and CD34, 4 populations of post-5-FU marrow cells were analyzed. The majority of the stem cells were in the CD38(-)CD34(+) fraction. However, secondary transplantation experiments indicated that when the bone marrow reaches steady state, the majority of the stem cells become CD38(+)CD34(-). In addition, the minority populations of CD34(+) stem cells that occur in steady-state bone marrow are CD38(-). This reversible and reciprocal expression of CD38 and CD34 by murine stem cells may have implications for the phenotypes of human stem cells.

[1]  T. Ito,et al.  Developmental changes of CD34 expression by murine hematopoietic stem cells. , 2000, Experimental hematology.

[2]  M. Ogawa,et al.  CD34 expression by murine hematopoietic stem cells mobilized by granulocyte colony-stimulating factor. , 2000, Blood.

[3]  M. Ogawa,et al.  Reversible expression of CD34 by murine hematopoietic stem cells. , 1999, Blood.

[4]  C. Civin,et al.  Biology of CD34+CD38- cells in lymphohematopoiesis. , 1998, Leukemia & lymphoma.

[5]  D. Cockayne,et al.  Mice deficient for the ecto-nicotinamide adenine dinucleotide glycohydrolase CD38 exhibit altered humoral immune responses. , 1998, Blood.

[6]  M. Yoder,et al.  c-Kit and CD38 are expressed by long-term reconstituting hematopoietic cells present in the murine yolk sac. , 1998, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[7]  R. Johnson,et al.  Dye efflux studies suggest that hematopoietic stem cells expressing low or undetectable levels of CD34 antigen exist in multiple species , 1997, Nature Medicine.

[8]  C. Civin,et al.  Sustained, retransplantable, multilineage engraftment of highly purified adult human bone marrow stem cells in vivo. , 1996, Blood.

[9]  F. Prósper,et al.  Phenotypic and functional characterization of long-term culture-initiating cells present in peripheral blood progenitor collections of normal donors treated with granulocyte colony-stimulating factor. , 1996, Blood.

[10]  Hiromitsu Nakauchi,et al.  Long-Term Lymphohematopoietic Reconstitution by a Single CD34-Low/Negative Hematopoietic Stem Cell , 1996, Science.

[11]  I. Weissman,et al.  Expression of murine CD38 defines a population of long-term reconstituting hematopoietic stem cells. , 1996, Blood.

[12]  N. Solvason,et al.  Murine CD38: an immunoregulatory ectoenzyme. , 1995, Immunology today.

[13]  E. Smeland,et al.  Functional differences between CD38- and DR- subfractions of CD34+ bone marrow cells. , 1994, Blood.

[14]  F. Malavasi,et al.  Human CD38: a glycoprotein in search of a function. , 1994, Immunology today.

[15]  P. Lansdorp,et al.  Sequential generations of hematopoietic colonies derived from single nonlineage-committed CD34+CD38- progenitor cells. , 1991, Blood.

[16]  E. Reinherz,et al.  Discrete stages of human intrathymic differentiation: analysis of normal thymocytes and leukemic lymphoblasts of T-cell lineage. , 1980, Proceedings of the National Academy of Sciences of the United States of America.

[17]  D. Harrison,et al.  Loss of proliferative capacity in immunohemopoietic stem cells caused by serial transplantation rather than aging , 1978, The Journal of experimental medicine.

[18]  I. Weissman,et al.  Phenotypic and functional changes induced at the clonal level in hematopoietic stem cells after 5-fluorouracil treatment. , 1997, Blood.